You are here » Media » Press releases

Press Releases

Entries for 2009

September 21, 2009

This market authorisation is part of a process including 15 countries in Europe. Azzalure ® will be commercialised in Spain by Galderma. Lausa...

Read more...

Posted in: Press release

June 26, 2009

This market authorisation is part of a process including 15 countries in Europe. Azzalure ® will be commercialised in Germany by Galderma Laus...

Read more...

Posted in: Press release

March 30, 2009

Lausanne (Switzerland) and Paris (France), 30 March 2009 – Galderma, the leading pharmaceutical company in dermatology, and Ipsen (Euronext: IPN), an ...

Read more...

Posted in: Press release

March 12, 2009

First market authorisation of 15 for Azzalure ® in Europe Azzalure ® will be commercialised by Galderma Lausanne (Switzerland) and Paris (Fran...

Read more...

Posted in: Press release

February 03, 2009

Fort Worth, TX – February 3, 2009 – Galderma Laboratories, L.P. today announced that the U.S. Food and Drug Administration (FDA) has approved Vectical™ (calcitriol) Ointment 3mcg/g, a unique vitamin D3 product for the treatment of mild-to-moderate plaque psoriasis in adults.

Read more...

Posted in: Press release

 1 / 2  

Follow us Follow us on twitter Follow us on Linkedin

Corporate responsibility

Growing a responsible dermatological community

Discover some of the positive initiatives we are involved in across the world

Read

Video

We are committed

See all videos